PMID- 9778221 OWN - NLM STAT- MEDLINE DCOM- 19981103 LR - 20131121 IS - 0004-3591 (Print) IS - 0004-3591 (Linking) VI - 41 IP - 10 DP - 1998 Oct TI - Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy. PG - 1806-12 AB - OBJECTIVE: To define the mechanisms of action of 2 novel drugs, cyclosporine and anti-tumor necrosis factor alpha (TNFalpha), in collagen-induced arthritis and to determine the effect of combination therapy. METHODS: Type II collagen-immunized DBA/1 mice with established arthritis were treated with cyclosporine alone, anti-TNFalpha alone, cyclosporine plus anti-TNFalpha, or saline. RESULTS: Cyclosporine was found to ameliorate arthritis, suppress interferon-gamma (IFNgamma) production by CD4+ T cells, and reduce TNFalpha expression in arthritic joints. However, cyclosporine did not directly inhibit TNFalpha production by macrophages, indicating that the decrease in TNFalpha expression observed in vivo was probably an indirect consequence of the reduction in type 1 T helper cell activity. Anti-TNFalpha also reduced IFNgamma production by T cells, indicating that TNFalpha is involved in the cellular immune response to collagen. Combined treatment with cyclosporine plus anti-TNFalpha had an additive therapeutic effect. CONCLUSION: Although cyclosporine and anti-TNFalpha target different points in the inflammatory pathway, there is an overlap in the consequences of their actions in vivo. FAU - Williams, R O AU - Williams RO AD - Kennedy Institute of Rheumatology, London, UK. FAU - Mauri, C AU - Mauri C FAU - Mason, L J AU - Mason LJ FAU - Marinova-Mutafchieva, L AU - Marinova-Mutafchieva L FAU - Ross, S E AU - Ross SE FAU - Feldmann, M AU - Feldmann M FAU - Maini, R N AU - Maini RN LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Arthritis Rheum JT - Arthritis and rheumatism JID - 0370605 RN - 0 (Antibodies, Monoclonal) RN - 0 (Tumor Necrosis Factor-alpha) RN - 83HN0GTJ6D (Cyclosporine) RN - 9007-34-5 (Collagen) SB - IM MH - Animals MH - Antibodies, Monoclonal/*therapeutic use MH - Arthritis, Experimental/*drug therapy/immunology MH - Collagen/*immunology MH - Cyclosporine/*therapeutic use MH - Dose-Response Relationship, Drug MH - Drug Therapy, Combination MH - Male MH - Mice MH - Mice, Inbred DBA MH - Th1 Cells/drug effects/immunology MH - Tumor Necrosis Factor-alpha/immunology EDAT- 1998/10/20 00:00 MHDA- 1998/10/20 00:01 CRDT- 1998/10/20 00:00 PHST- 1998/10/20 00:00 [pubmed] PHST- 1998/10/20 00:01 [medline] PHST- 1998/10/20 00:00 [entrez] AID - 10.1002/1529-0131(199810)41:10<1806::AID-ART12>3.0.CO;2-9 [doi] PST - ppublish SO - Arthritis Rheum. 1998 Oct;41(10):1806-12. doi: 10.1002/1529-0131(199810)41:10<1806::AID-ART12>3.0.CO;2-9.